Bariatric surgery to reduce cardiovascular events in obese patients
Official title: Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial
Run by Population Health Research Institute · NCT05531474 · Data updated 2026-11-12
This study tests if bariatric surgery can help people with severe obesity and heart disease lower their risk of serious heart problems better than just medical weight management.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 700 (estimated) |
| Sponsor | Population Health Research Institute Academic / other |
| Locations | 1 site (Hamilton, Ontario) |
| Status | Recruiting |
| Started | November 2, 2020 |
| Main results expected | July 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | May 28, 2026 |
| Trial ID | NCT05531474 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with a BMI of 30 kg/m2 or higher and high-risk cardiovascular disease.
✕Probably not a fit
Patients who are not severely obese or do not have high-risk cardiovascular conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of bariatric surgery compared to medical weight management in patients with severe obesity and high-risk cardiovascular disease. It aims to determine if bariatric surgery can safely reduce the risk of major cardiovascular events. Additionally, the study will explore the cost-effectiveness of the surgery and conduct sub-studies on its impact on mental health, cardiac structure and function, as well as genomics, proteomics, and metabolomics.
Why it matters
Potential benefit: If successful, this approach could significantly lower the risk of cardiovascular events in obese patients with existing heart conditions.
How similar studies have gone: Previous studies have shown promising results for bariatric surgery in improving cardiovascular outcomes, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Body mass index ≥30 kg/m2; OR BMI ≥30 kg/m2 to 34.9 kg/m2 and have type 2 diabetes or are \>55 years of age 2. Age ≥18 years 3. High-risk CVD, defined as the presence of any one of the following: 1. High-risk coronary artery disease (CAD) (i.e., history of MI, percutaneous coronary intervention, coronary artery bypass grafting, or stenoses ≥ 50% in 2 or more major coronary arteries) 2. Left ventricular ejection fraction (LVEF) \< 40% 3. Heart failure with preserved ejection fraction (LVEF \> 40%) and either HF hospitalization in the last 2-years or N-terminal pro b-type natriuretic peptide (NT-proBNP) \> 300 pg/ml or BNP \> 100 pg/ml in the past 12 months 4. Documented atrial fibrillation (AF) with CHA2DS2-VASc ≥2 stroke risk score 5. History of any stroke 6. Documented peripheral arterial disease (PAD) (i.e., peripheral revascularization of the iliac, infra-inguinal or carotid arteries; limb or foot amputation for arterial vascular disease; or ≥50% carotid or peripheral artery stenosis) Exclusion Criteria: 1. Hospital admission for HF, myocardial infarction, stroke or coronary revascularization within 30 days of randomization 2. Percutaneous coronary intervention with a drug eluting stent within 90 days of randomization. 3. Pregnancy 4. Contraindication to bariatric surgery 5. Prior bariatric surgery, other than gastric banding 6. Life expectancy \<2 years from non-cardiovascular causes 7. Inability to provide informed consent
Where it's running
-
Hamilton Health Sciences
Hamilton, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Salim Yusuf, DPhil, DSc (Oxon), FRCPC, FRSC — Population Health Research Institute
- Study coordinator: Jorge Wong, MD, MPH, FRCPC
- Email: jorge.wong@phri.ca
- Phone: 905-521-2100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transcutaneous Nerve Stimulation to Help Breathing After Bariatric Surgery
A randomized trial tests whether a skin-placed nerve stimulator can reduce diaphragmatic dysfunction after bariatric surgery in people with obesity.
-
Stress response with desflurane versus opioid-free TIVA during weight-loss surgery
This study will test whether adding the inhaled anesthetic desflurane to opioid-free anesthesia changes the body's perioperative stress response in people having bariatric (weight-loss) surgery.
-
Cardiovascular Outcomes After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors
This study tests how often and what kinds of cardiovascular problems occur after adrenalectomy for pheochromocytoma or non-secreting tumors.
-
Tropicamide/phenylephrine safety in hospitalized patients
This project will see if certain health factors make hospitalized adults more likely to have side effects after getting tropicamide/phenylephrine eye drops.
-
Autonomic Nerve Blockade to Reduce Pain and Nausea After Bariatric Surgery
This study tests whether an autonomic nerve block given during bariatric surgery can lessen pain and nausea and decrease the need for anti-nausea and pain medicines in the first 72 hours after sleeve gastrectomy or gastric bypass.
-
Effects of bile acids on glucose metabolism after gastric bypass surgery
This study is testing how bile acids affect blood sugar levels in people who have had gastric bypass surgery by giving some participants a medication and comparing their results to others.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.